Aliveda, with the patronage of the Italian Association of amyotrophic lateral sclerosis is delighted to invite to the conference “Amyotrophic lateral sclerosis: new mechanism of neurodegeneration for new therapies; development of a collaborative project”. The meeting will be on the 28th-29th October 2016 on the hills around Pisa, and it was thought as a moment of update on the newest hypothesis on the origins of the disease, how these can bring new therapeutical progresses and on the most valuable mean to conceive, develop and manage clinical trials, which answer fast to patients need.
The meeting will be organized in short sessions held by professionals of the disease, followed by moment of discussions.
During the meeting, it will be presented Alibrain Advanced, an innovative formulation developed in Aliveda laboratories, which is tested in a clinical trial run by the Neurological Department of Santa Chiara Hospital in Pisa, run by Prof. Siciliano.
Moreover, there will be a moment of discussion between the representatives of patient associations, to improve our work and strengthen the common intents against amyotrophic lateral sclerosis.
Aliveda presents the new Chief Commercial Officer
Alessandro Toscano is the new Chief Commercial Officer for A